Immunohistochemical Array for Clear Cell Type Mucoepidermoid Carcinoma
±è¿¬¼÷, ÀÌ»ó½Å, ¼ÛÁö¿ë, ±èÀºÃ¶, À̼®±Ù,
¼Ò¼Ó »ó¼¼Á¤º¸
±è¿¬¼÷ ( Kim Yeon-Sook )
ûÁÖ´ëÇб³ Ä¡°ú´ëÇÐ Ä¡À§»ýÇаú
ÀÌ»ó½Å ( Lee Sang-Shin )
°¸ª¿øÁÖ´ëÇб³ Ä¡°ú´ëÇÐ ±¸°º´¸®Çб³½Ç
¼ÛÁö¿ë ( Song Ji-Yong )
°¸ª¿øÁÖ´ëÇб³ Ä¡°ú´ëÇÐ ±¸°º´¸®Çб³½Ç
±èÀºÃ¶ ( Kim Eun-Cheol )
¿ø±¤´ëÇб³ Ä¡°ú´ëÇÐ ±¸°¾Ç¾È¸éº´¸®Çб³½Ç
À̼®±Ù ( Lee Suk-Keun )
°¸ª¿øÁÖ´ëÇб³ Ä¡°ú´ëÇÐ ±¸°º´¸®Çб³½Ç
KMID : 0357920100440030284
Abstract
Background: The protein expression profile of clear cell type mucoepidermoid carcinoma (MEC) is not well known.
Methods: We examined a case of clear cell type MEC by immunohistochemical (IHC) array using 59 antibodies against oncoproteins, proliferation-related proteins, apoptosis-related proteins, growth factor-related proteins, angiogenesis-related proteins, and matrix proteins.
Results: MEC tumor cells showed 40 to 60% more expression of BCL-2 and cyclin-dependent kinase 4 than normal gingival tissue, and 20-40% more expression of BCL-2-associated agonist of cell death, deleted in malignant brain tumors 1, E-cadherin, eIF5A, hypoxia-inducible factor, vimentin, and Wnt-1. Expression of other proteins, including p53, epidermal growth factor receptor, proliferating cell nuclear antigen, survivin, carcinoembryonic antigen, ¥â-catenin, poly-ADP ribose-polymerase, etc. were relatively weak in MEC tumor cells.
Conclusions: The IHC array for our MEC contained strong oncogenic signals involving Wnt-1/adenomatous polyposis coli, tumor necrosis factor a/signal transducer and activator of transcription 3/BCL-2, and pAKT pathways, signals that could result in the prolonged survival of clear tumor cells.
Å°¿öµå
Oncogenes;Immunohistochemistry;Array
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸